Crescent Biopharma, Inc.
USD18.24
+0.24 (+1.35%)
CEO
Joshua T. Brumm
IPO Date
2014-01-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.00
Prev. Close
$18.00
Day Low
$17.57
Day High
$18.41
52W Low
$8.72
52W High
$27.41
Market Cap
$0.50B
Volume
0.02M
| -10.0 |
| 31 Dec 2023 | FY | 100.0% | -368994.2% | -96.1% | -81.4% | 0.02 | 6.41 | -405.1 |
| 31 Dec 2022 | FY | 100.0% | -62251.7% | -108.8% | -90.1% | 0.02 | 5.71 | -340.9 |
| 31 Dec 2021 | FY | 100.0% | -5469.0% | -77.7% | -67.2% | 0.02 | 7.68 | -116.8 |
| 31 Dec 2020 | FY | 0.0% | -502.1% | -39.8% | -35.7% | 0.02 | 11.13 | -336.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -35.1% | -32.2% | 0.02 | 14.84 | -422.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -23.5% | -22.5% | 0.00 | 24.22 | -805.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -27.8% | -25.9% | 0.00 | 15.56 | -1483.0 |
| 31 Dec 2016 | FY | 0.0% | -171945.1% | -90.1% | -75.0% | 0.00 | 6.40 | -407.6 |
| -0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -21.1% | -17.8% | 0.03 | 6.63 | -2.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.6% | -13.8% | 0.02 | 9.21 | -0.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -448.8% | -252.8% | 0.00 | 2.29 | -6.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -336.3% | -161.1% | 0.01 | 1.92 | -6.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -86.4% | -62.6% | 0.02 | 3.62 | -27.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -50.3% | -41.3% | 0.02 | 5.48 | -47.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -37.1% | -31.4% | 0.02 | 6.28 | -456.3 |
| 31 Dec 2023 | Q4 | 100.0% | -90786.4% | -23.6% | -20.0% | 0.02 | 6.41 | -418.5 |